logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Sep 6, 2017

PharmaCyte Restructures Agreements with Austrianova to Strengthen Partnership

  • Jul 26, 2017

PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer

  • Jul 10, 2017

PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors

  • Jul 6, 2017

PharmaCyte Biotech Releases Presentation to Oncologists and Interviews from 2017 ASCO Meeting Event

  • Jun 13, 2017

PharmaCyte Biotech to Present Pancreatic Cancer Therapy at 2017 BIO International Convention

  • Jun 9, 2017

PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists

  • May 31, 2017

PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology

  • May 8, 2017

PharmaCyte Biotech Updates IND Submission Process in Interview with Facet Life Sciences

  • May 2, 2017

PharmaCyte Biotech Appoints Thomas Yuen to Board of Directors

  • Apr 19, 2017

PharmaCyte Biotech Receives the 2017 “Pipelines of Promise” Award from BIO International

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • Next »

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells July 5, 2022
  • PharmaCyte Biotech Issues Follow-Up Response to Iroquois Capital’s Second Letter on June 9 and Reiterates Commitment to Increasing Shareholder Value June 15, 2022